Tablet having a two-dimensional identifier
AssigneesLaxxon Medical AG, Exentis Knowledge GmbH
InventorsKlaus Kühne, Helmut Kerschbaumer, Daniel Moldenhauer, Alexander Ruckdäschel, Achim Schneeberger
Life of this patent
Estimating the term…
Abstract
A solid dosage form for active ingredient release can be a preparation for medical, dental or cosmetic purposes, and is preferably a tablet. The solid dosage form comprises a three-dimensional base body which comprises an active ingredient. The solid dosage form further comprises a portion having a structure forming a two-dimensional identifier, such as, for instance, a QR code.
Claims20
A solid dosage form for active ingredient release, the solid dosage form contained in a tablet comprising:
- a three-dimensional base body, wherein the three-dimensional base body comprises an active ingredient, and
- a portion having a structure forming a two-dimensional identifier,
- wherein the portion is integral with the three-dimensional base body.
A method for production by means of screen printing of a dosage form, the method comprising:
- providing a first printing paste comprising an active ingredient;
- applying the first printing paste by means of a first printing screen;
- providing a second printing paste comprising a colouring agent;
- and
- applying the second printing paste by means of a second printing screen to form a portion of the dosage form, wherein the portion has a structure forming a two-dimensional identifier of the dosage form,
- wherein a pattern of the second printing screen defines a structure of the portion.
Dependencies are inferred from the claim text.